Tylenol’s parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.
Related Posts
Eliminar a malária no Brasil é necessário… e possível
No início da década de 1940, dois terços da população do Brasil viviam em áreas endêmicas de malária. A estimativa…
Russian Missile and Drone Attack Kills at Least 14 in Kyiv
The strikes on Ukraine’s capital, nearly two weeks after the U.S.-Russia summit in Alaska, injured at least 45 people, officials…
Fall foliage to be more ‘vibrant,’ last longer this year in Ontario
Fall 2025 isn’t officially here yet but the season’s foliage is arriving earlier than usual and experts predict it will…